FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7602711000001106: Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
29413501000001119 Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
67062401000001118 Trisenox 10mg/10ml concentrate for solution for infusion ampoules (Teva UK Ltd) 10 ampoule en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Is a Arsenic 10mg/10ml solution for injection ampoules 10 ampoule true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Is pack of Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has active ingredient Arsenic trioxide false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has AMP Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has specific active ingredient Arsenic trioxide true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Trisenox 10mg/10ml solution for injection (Cell Therapeutics (UK) Ltd) 10 ampoule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start